US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist
  • 1.600
  • +0.010+0.63%
Close Nov 27 16:00 ET
  • 1.600
  • 0.0000.00%
Post 20:01 ET
82.80MMarket Cap-1600P/E (TTM)

PMV Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.54%-16.84M
87.61%-1.6M
-7.81%-16.18M
12.71%-55.66M
21.14%-12.09M
6.56%-15.66M
5.69%-12.9M
16.59%-15.01M
-36.91%-63.76M
-27.40%-15.32M
Net income from continuing operations
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
-26.75%-73.32M
-5.37%-19.35M
Depreciation and amortization
3.63%371K
0.81%372K
111.70%362K
299.05%1.26M
378.67%359K
383.78%358K
350.00%369K
103.57%171K
2.61%315K
-2.60%75K
Other non cash items
-65.26%-157K
-4.08%-102K
6.67%-84K
-252.26%-370K
-210.13%-87K
-231.94%-95K
-1,188.89%-98K
-208.43%-90K
-74.55%243K
-75.91%79K
Change In working capital
254.84%1.18M
-198.94%-2.05M
-219.78%-2.17M
1,055.46%5.43M
72.11%2.31M
14.73%-764K
117.68%2.07M
192.46%1.82M
-113.78%-568K
-67.04%1.34M
-Change in prepaid assets
-1,682.35%-909K
-307.54%-1.35M
-108.02%-169K
194.20%1.72M
-368.12%-984K
97.30%-51K
5.52%650K
328.14%2.11M
-4,913.16%-1.83M
-79.39%367K
-Change in payables and accrued expense
392.57%2.09M
-166.15%-938K
-584.30%-2.01M
267.86%2.87M
739.32%2.46M
-171.80%-713K
388.21%1.42M
83.95%-293K
-141.81%-1.71M
-116.79%-384K
-Change in other current liabilities
----
----
----
-71.81%837K
----
----
----
----
--2.97M
----
-Change in other working capital
--6K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-7.54%-16.84M
87.61%-1.6M
-7.81%-16.18M
12.71%-55.66M
21.14%-12.09M
6.56%-15.66M
5.69%-12.9M
16.59%-15.01M
-36.91%-63.76M
-27.40%-15.32M
Investing cash flow
Cash flow from continuing investing activities
150.89%17.12M
103.63%2.32M
-47.29%26.17M
-3,594.81%-50.55M
-111.14%-2.59M
-213.98%-33.64M
-318.63%-63.96M
227.87%49.65M
99.05%-1.37M
207.22%23.22M
Net PPE purchase and sale
163.64%28K
99.29%-4K
-280.77%-594K
87.95%-962K
87.97%-197K
97.85%-44K
83.86%-565K
80.40%-156K
-491.85%-7.98M
-525.19%-1.64M
Net investment purchase and sale
150.87%17.09M
103.67%2.33M
-46.27%26.76M
-849.44%-49.58M
-109.62%-2.39M
-206.44%-33.6M
-438.23%-63.4M
230.96%49.8M
104.65%6.62M
217.87%24.86M
Cash from discontinued investing activities
Investing cash flow
150.89%17.12M
103.63%2.32M
-47.29%26.17M
-3,594.81%-50.55M
-111.14%-2.59M
-213.98%-33.64M
-318.63%-63.96M
227.87%49.65M
99.05%-1.37M
207.22%23.22M
Financing cash flow
Cash flow from continuing financing activities
0
-93.38%141K
0
3,613.67%35.58M
-47.45%288K
552,333.33%33.15M
672.10%2.13M
-90.63%12K
-52.62%958K
85.76%548K
Net common stock issuance
--0
----
----
--35.12M
--0
--33.1M
----
----
--0
--0
Proceeds from stock option exercised by employees
--0
34.29%141K
--0
-52.40%456K
-47.45%288K
750.00%51K
-61.96%105K
-90.63%12K
-52.62%958K
85.76%548K
Cash from discontinued financing activities
Financing cash flow
--0
-93.38%141K
--0
3,613.67%35.58M
-47.45%288K
552,333.33%33.15M
672.10%2.13M
-90.63%12K
-52.62%958K
85.76%548K
Net cash flow
Beginning cash position
-28.51%49.35M
-66.28%48.48M
-64.69%38.53M
-37.03%109.12M
-47.47%52.88M
-21.48%69.03M
23.30%143.76M
-37.03%109.12M
-52.05%173.29M
-43.27%100.67M
Current changes in cash
101.73%280K
101.16%866K
-71.19%9.98M
-10.06%-70.63M
-270.30%-14.39M
-226.58%-16.15M
-160.56%-74.73M
161.11%34.65M
65.89%-64.17M
302.37%8.45M
Effect of exchange rate changes
--4K
--6K
---34K
--34K
--34K
--0
----
----
--0
----
End cash Position
-6.14%49.63M
-28.51%49.35M
-66.28%48.48M
-64.69%38.53M
-64.69%38.53M
-47.47%52.88M
-21.48%69.03M
23.30%143.76M
-37.03%109.12M
-37.03%109.12M
Free cash flow
-7.24%-16.84M
88.10%-1.6M
-10.61%-16.78M
21.08%-56.62M
27.59%-12.28M
16.51%-15.7M
21.61%-13.47M
19.29%-15.17M
-49.72%-71.74M
-38.01%-16.96M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.54%-16.84M87.61%-1.6M-7.81%-16.18M12.71%-55.66M21.14%-12.09M6.56%-15.66M5.69%-12.9M16.59%-15.01M-36.91%-63.76M-27.40%-15.32M
Net income from continuing operations -15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M-26.75%-73.32M-5.37%-19.35M
Depreciation and amortization 3.63%371K0.81%372K111.70%362K299.05%1.26M378.67%359K383.78%358K350.00%369K103.57%171K2.61%315K-2.60%75K
Other non cash items -65.26%-157K-4.08%-102K6.67%-84K-252.26%-370K-210.13%-87K-231.94%-95K-1,188.89%-98K-208.43%-90K-74.55%243K-75.91%79K
Change In working capital 254.84%1.18M-198.94%-2.05M-219.78%-2.17M1,055.46%5.43M72.11%2.31M14.73%-764K117.68%2.07M192.46%1.82M-113.78%-568K-67.04%1.34M
-Change in prepaid assets -1,682.35%-909K-307.54%-1.35M-108.02%-169K194.20%1.72M-368.12%-984K97.30%-51K5.52%650K328.14%2.11M-4,913.16%-1.83M-79.39%367K
-Change in payables and accrued expense 392.57%2.09M-166.15%-938K-584.30%-2.01M267.86%2.87M739.32%2.46M-171.80%-713K388.21%1.42M83.95%-293K-141.81%-1.71M-116.79%-384K
-Change in other current liabilities -------------71.81%837K------------------2.97M----
-Change in other working capital --6K------------------------------------
Cash from discontinued investing activities
Operating cash flow -7.54%-16.84M87.61%-1.6M-7.81%-16.18M12.71%-55.66M21.14%-12.09M6.56%-15.66M5.69%-12.9M16.59%-15.01M-36.91%-63.76M-27.40%-15.32M
Investing cash flow
Cash flow from continuing investing activities 150.89%17.12M103.63%2.32M-47.29%26.17M-3,594.81%-50.55M-111.14%-2.59M-213.98%-33.64M-318.63%-63.96M227.87%49.65M99.05%-1.37M207.22%23.22M
Net PPE purchase and sale 163.64%28K99.29%-4K-280.77%-594K87.95%-962K87.97%-197K97.85%-44K83.86%-565K80.40%-156K-491.85%-7.98M-525.19%-1.64M
Net investment purchase and sale 150.87%17.09M103.67%2.33M-46.27%26.76M-849.44%-49.58M-109.62%-2.39M-206.44%-33.6M-438.23%-63.4M230.96%49.8M104.65%6.62M217.87%24.86M
Cash from discontinued investing activities
Investing cash flow 150.89%17.12M103.63%2.32M-47.29%26.17M-3,594.81%-50.55M-111.14%-2.59M-213.98%-33.64M-318.63%-63.96M227.87%49.65M99.05%-1.37M207.22%23.22M
Financing cash flow
Cash flow from continuing financing activities 0-93.38%141K03,613.67%35.58M-47.45%288K552,333.33%33.15M672.10%2.13M-90.63%12K-52.62%958K85.76%548K
Net common stock issuance --0----------35.12M--0--33.1M----------0--0
Proceeds from stock option exercised by employees --034.29%141K--0-52.40%456K-47.45%288K750.00%51K-61.96%105K-90.63%12K-52.62%958K85.76%548K
Cash from discontinued financing activities
Financing cash flow --0-93.38%141K--03,613.67%35.58M-47.45%288K552,333.33%33.15M672.10%2.13M-90.63%12K-52.62%958K85.76%548K
Net cash flow
Beginning cash position -28.51%49.35M-66.28%48.48M-64.69%38.53M-37.03%109.12M-47.47%52.88M-21.48%69.03M23.30%143.76M-37.03%109.12M-52.05%173.29M-43.27%100.67M
Current changes in cash 101.73%280K101.16%866K-71.19%9.98M-10.06%-70.63M-270.30%-14.39M-226.58%-16.15M-160.56%-74.73M161.11%34.65M65.89%-64.17M302.37%8.45M
Effect of exchange rate changes --4K--6K---34K--34K--34K--0----------0----
End cash Position -6.14%49.63M-28.51%49.35M-66.28%48.48M-64.69%38.53M-64.69%38.53M-47.47%52.88M-21.48%69.03M23.30%143.76M-37.03%109.12M-37.03%109.12M
Free cash flow -7.24%-16.84M88.10%-1.6M-10.61%-16.78M21.08%-56.62M27.59%-12.28M16.51%-15.7M21.61%-13.47M19.29%-15.17M-49.72%-71.74M-38.01%-16.96M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data